Oxidation of PTH: in vivo feature or effect of preanalytical conditions?
- PMID: 28809747
- DOI: 10.1515/cclm-2017-0313
Oxidation of PTH: in vivo feature or effect of preanalytical conditions?
Abstract
Background: Posttranslational oxidation of parathyroid hormone (PTH) modifies its biological activity. Measurement of non-oxidized PTH (n-oxPTH) could be an improvement in assessing PTH status, as intact PTH may rather reflect oxidative stress. However, it is debated whether oxidation of PTH occurs in vivo, or whether it is mainly an in vitro artifact. The aim of this study was to investigate the influence of different preanalytical conditions on the oxidation of PTH within a wide range of plasma PTH concentrations and oxidation propensity.
Methods: n-oxPTH was separated from its oxidized form using an affinity column capturing the oxidized PTH. n-oxPTH was measured in eluate using commercially available PTH assays. The study included ethylenediaminetetraacetic acid plasma samples from 17 patients undergoing hemodialysis and 32 healthy subjects. We determined effects of storage temperature, time until centrifugation and freeze-thaw cycles. PTH and n-oxPTH concentrations were measured in each sample using six different immunoassays.
Results: n-oxPTH concentrations remained unchanged up to 180 min until centrifugation, two freeze-thaw cycles or after storage at -20°C or -80°C up to 79 days. Various methods for n-oxPTH and PTH measurements yielded highly comparable results, apart from standardization differences between various PTH and n-oxPTH assays.
Conclusions: n-oxPTH concentrations were stable under our study conditions, indicating negligible ex vivo oxidation of PTH. In addition, PTH immunoassays have a different sensitivity for n-oxPTH than for total PTH. For this reason, the n-oxPTH/total PTH ratio cannot be used in absence of a n-oxPTH standard. Clinical implications of determining n-oxPTH require additional study.
Keywords: bone turnover markers; hemodialysis; method comparison; oxidative stress; parathyroid hormone; preanalytical phase.
Similar articles
-
Nonoxidized, biologically active parathyroid hormone determines mortality in hemodialysis patients.J Clin Endocrinol Metab. 2013 Dec;98(12):4744-51. doi: 10.1210/jc.2013-2139. Epub 2013 Oct 30. J Clin Endocrinol Metab. 2013. PMID: 24171919
-
Modeling of oxidized PTH (oxPTH) and non-oxidized PTH (n-oxPTH) receptor binding and relationship of oxidized to non-oxidized PTH in children with chronic renal failure, adult patients on hemodialysis and kidney transplant recipients.Kidney Blood Press Res. 2013;37(4-5):240-51. doi: 10.1159/000350149. Epub 2013 Jul 14. Kidney Blood Press Res. 2013. PMID: 23868100
-
Relationship between GFR, intact PTH, oxidized PTH, non-oxidized PTH as well as FGF23 in patients with CKD.FASEB J. 2020 Nov;34(11):15269-15281. doi: 10.1096/fj.202000596R. Epub 2020 Sep 22. FASEB J. 2020. PMID: 32964520
-
Oxidation of parathyroid hormone.Clin Chim Acta. 2020 Jul;506:84-91. doi: 10.1016/j.cca.2020.03.020. Epub 2020 Mar 13. Clin Chim Acta. 2020. PMID: 32178977 Review.
-
Unlocking the mysteries of n-oxPTH: implications for CKD patients.Front Endocrinol (Lausanne). 2025 Jan 3;15:1455783. doi: 10.3389/fendo.2024.1455783. eCollection 2024. Front Endocrinol (Lausanne). 2025. PMID: 39829956 Free PMC article. Review.
Cited by
-
The path to the standardization of PTH: Is this a realistic possibility? a position paper of the IFCC C-BM.Clin Chim Acta. 2021 Apr;515:44-51. doi: 10.1016/j.cca.2020.12.022. Epub 2021 Jan 4. Clin Chim Acta. 2021. PMID: 33412144 Free PMC article.
-
Inverse correlation of intact PTH, oxidized PTH as well as non-oxidized PTH with 25-hydroxyvitamin D3 in kidney transplant recipients.Front Endocrinol (Lausanne). 2023 May 31;14:1178166. doi: 10.3389/fendo.2023.1178166. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37324252 Free PMC article.
-
Exogenous Parathyroid Hormone Alleviates Intervertebral Disc Degeneration through the Sonic Hedgehog Signalling Pathway Mediated by CREB.Oxid Med Cell Longev. 2022 Feb 27;2022:9955677. doi: 10.1155/2022/9955677. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35265269 Free PMC article.
-
Parathyroid Hormone Measurement in Chronic Kidney Disease: From Basics to Clinical Implications.Int J Nephrol. 2019 Sep 17;2019:5496710. doi: 10.1155/2019/5496710. eCollection 2019. Int J Nephrol. 2019. PMID: 31637056 Free PMC article. Review.
-
The effect of vitamin D supplementation on plasma non-oxidised PTH in a randomised clinical trial.Endocr Connect. 2019 May 1;8(5):518-527. doi: 10.1530/EC-19-0097. Endocr Connect. 2019. PMID: 30959477 Free PMC article.
References
-
- Poole KE, Reeve J. Parathyroid hormone – a bone anabolic and catabolic agent. Curr Opin Pharmacol 2005;5:612–7.
-
- Journal O, The OF, Society I, Nephrology OF. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009;76:S1–130.
-
- Fraser WD. Seminar hyperparathyroidism. Lancet 2009;374: 145–58.
-
- Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 2011;26:1948–55.
-
- Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2008;52: 519–30.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources